This slide is about diabetes care I presented on April 9th, 2015. My audience is a group of elder people who has interest in this topic, some of them are patients, some are family members. Most of the slides are Chinese because my audience use Chinese most. My targets are to let people understand what are their sugar-control medicine do their jobs and what they should be aware while using them.
Carbohydrate Counting for insulin dose adjustmentltejas86
Carbohydrate counting is the method of estimating carbohydrates from your meal and adjusting insulin dose to keep blood sugar levels under control. It is easy and very effective specially for children with type 1 diabetes. It offers variety and flexibility in the diet at the same time improves blood sugar profile.
SGLT2I The paradigm change in diabetes managementPraveen Nagula
Just like ARNI, SGLT2I have changed the face of diabetes management and they have a good profile in multimodality management because of pleiotropic effects
Insulin Initiation : When We should Start with Basal Insulin?mataharitimoer MT
Insulin Initiation : When We should Start with Basal Insulin?
Dr. Agus Taolin , SpPD, FINASIM | PAPDI CABANG BOGOR
Disampaikan pada acara PIT VI IDI Kota Bogor | 9 Nopember 2013
The use of vildagliptin in patients with type 2 diabetes with renal impairmentUsama Ragab
The use of vildagliptin in patients with type 2 diabetes with renal impairment
By Dr. Usama Ragab Youssif
Agenda
----------
Case presentation
Diabetes and CKD: What is the problem
Drug treatment in patient with CKD: choice of treatment
Vildagliptin in mild renal impairment
Vildagliptin in moderate and severe renal impairment
Vildagliptin in ESRD (patients on HD)
Vildagliptin in kidney transplant patients with NODAT
Final bottom-line
Diabetic Dyslipidemia
By Dr. Usama Ragab Youssif
ISMA CME Activity 2021
In Tolip EL Galala Hotel
-----------
Introduction
Physiology of lipid metabolism
Pathophysiology of diabetic dyslipidemia
Statin therapy (+/- ezetimibe) evidence and translation of evidence
Residual CV risk: excess TG
EPA therapy evidence and translation of evidence
Carbohydrate Counting for insulin dose adjustmentltejas86
Carbohydrate counting is the method of estimating carbohydrates from your meal and adjusting insulin dose to keep blood sugar levels under control. It is easy and very effective specially for children with type 1 diabetes. It offers variety and flexibility in the diet at the same time improves blood sugar profile.
SGLT2I The paradigm change in diabetes managementPraveen Nagula
Just like ARNI, SGLT2I have changed the face of diabetes management and they have a good profile in multimodality management because of pleiotropic effects
Insulin Initiation : When We should Start with Basal Insulin?mataharitimoer MT
Insulin Initiation : When We should Start with Basal Insulin?
Dr. Agus Taolin , SpPD, FINASIM | PAPDI CABANG BOGOR
Disampaikan pada acara PIT VI IDI Kota Bogor | 9 Nopember 2013
The use of vildagliptin in patients with type 2 diabetes with renal impairmentUsama Ragab
The use of vildagliptin in patients with type 2 diabetes with renal impairment
By Dr. Usama Ragab Youssif
Agenda
----------
Case presentation
Diabetes and CKD: What is the problem
Drug treatment in patient with CKD: choice of treatment
Vildagliptin in mild renal impairment
Vildagliptin in moderate and severe renal impairment
Vildagliptin in ESRD (patients on HD)
Vildagliptin in kidney transplant patients with NODAT
Final bottom-line
Diabetic Dyslipidemia
By Dr. Usama Ragab Youssif
ISMA CME Activity 2021
In Tolip EL Galala Hotel
-----------
Introduction
Physiology of lipid metabolism
Pathophysiology of diabetic dyslipidemia
Statin therapy (+/- ezetimibe) evidence and translation of evidence
Residual CV risk: excess TG
EPA therapy evidence and translation of evidence
A slideshow for my collegues in hospitals on 2014 Oct 15th.
This presentation is about a case who developed resistance to lamivudine, an anti-HBV agent, during treatment. We discussed about how resistance develop, how to interpret resistance result, and how to optimize the therapy in lamivudine-resistant settings. Time to stop anti-viral agents is also discussed.
Brought to you by 由 http://www.facebook.com/RoadToWELLTH 提供
('Like 讚', SHOP 購物 & Get FREE Gifts 拿免費贈品!!)
Online Shopping:
http://bit.ly/wsenshp
網上即時購物盡在:
http://bit.ly/wszhshp
探索愛身健麗如何改變您的健康、財富、以及最重要的,您的一生。
Discover how Isagenix can transform your health, your wealth, and ultimately your life.
-----> http://www.RoadToWELLTH.isagenix.com
HbA1C may reduce microvascular complications, and if get controlled in early-diagnosed period, macrovascular complication may be
糖尿病的定義:
1. HbA1C > 6.5 %
2. Preprandial serum sugar > 126 mg/dL at least 8-hr apart from digestion
3. 2-hr plasma glucose > 200 mg/dL after a 75 anhydrous glucose dissolved in water (an OGTT)
4. Classic symptoms of hyperglycemia or a random plasma glucose > 200 mg/dL
Mechanism of metformin: Lower FPG concentrations by decreasing hepatic gluconeogenesis and increasing insulin-stimulated glucose uptake by skeletal muscle and adipose tissue.
Efficacy:FPG 50-70 mg/dL
PPG 83 mg/dL
Adverse effect:
Mechanism
TZDs bind to and activate a nuclear receptor (PPAR-γ). PPAR-γ regulates transcription of genes that influence glucose and lipid metabolism. For example, PPAR-γ stimulation increases the transcription of GLUT-4, a glucose transporter that stimulates glucose uptake.